UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062471
Receipt number R000071471
Scientific Title Development and Feasibility of Midwife-led Birth Review Considering for Psychological Birth Trauma
Date of disclosure of the study information 2026/11/10
Last modified on 2026/11/09 13:19:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development and Feasibility of Midwife-led Birth Review Considering for Psychological Birth Trauma

Acronym

A study of Birth Review Considering for Psychological Birth Trauma

Scientific Title

Development and Feasibility of Midwife-led Birth Review Considering for Psychological Birth Trauma

Scientific Title:Acronym

A study of Birth Review Considering for Psychological Birth Trauma

Region

Japan


Condition

Condition

Psychological Birth Trauma

Classification by specialty

Obstetrics and Gynecology Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to develop a midwife-led birth review intervention considering the psychological birth trauma, and to evaluate its feasibility (validity of the study methodology, acceptability of the intervention, efficacy and safety of the intervention, and implementability).

Basic objectives2

Others

Basic objectives -Others

Intervention receipt rate and post-intervention attrition rate

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Methodological validity: Evaluate the intervention receipt rate and the attrition rates post-intervention, and at 1 and 3 months postpartum.

Key secondary outcomes

-Methodological validity: Calculate Cronbach's alpha for each scale among participating postpartum women.
-Postpartum women's acceptability: Evaluate intervention satisfaction immediately post-intervention and at 3 months postpartum using the Japanese Client Satisfaction Questionnaire (CSQ-8). Assess optimal timing/frequency and emotional changes via a custom questionnaire.
-Intervention efficacy: Measure childbirth-related PTSD symptoms (Japanese PTSD Checklist for DSM-5), postpartum depression (Edinburgh Postnatal Depression Scale), self-esteem (Japanese Rosenberg Self-Esteem Scale), sense of mastery (Japanese Sense of Mastery Scale), and birth experience (Japanese Birth Satisfaction Scale-Revised [Japanese-BSS-R]) at baseline (pre-intervention) and post-intervention, and 1 and 3 months postpartum.
-Intervention safety: Assess childbirth-related PTSD symptoms using the Japanese PTSD Checklist for DSM-5 at baseline, post-intervention, and 1 and 3 months postpartum.
-Midwives' acceptability: Conduct midwife interviews to evaluate the birth review's utility, ease/clarity of use, burden, fit with clinical needs, and improvement suggestions.
-Implementability: Evaluate completion rates, time efficiency, and midwife interviews regarding protocol adherence challenges, orientation appropriateness, and implementation barriers.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

Intervention Group: Birth Review Considering for Psychological Birth Trauma
Within 4 days postpartum, a face-to-face birth review, developed based on meaning-making theory (Park, 2010) and midwife-led counseling by Gamble et al. (2009) effective in reducing posttraumatic stress symptoms after childbirth, will be conducted.

Interventions/Control_2

Control Group: Standard face-to-face birth review as part of routine care

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

50 years-old >

Gender

Female

Key inclusion criteria

Participants who meet all of the following criteria will be included. Recruitment will take place during the late stages of pregnancy.
(1) Female, aged 18 to under 50 at the time of consent
(2) Japanese is the first language of the participant
(3) At least 34 weeks pregnant
(4) Expecting to give birth
(5) Provided free and voluntary consent to participate in the study

Key exclusion criteria

Participants who meet any of the following criteria will be excluded.
(1) Receiving professional treatment for any mental illness (e.g., pharmacotherapy, cognitive behavioral therapy)
(2) Having experienced a stillbirth, neonatal death, or a serious congenital disorder in the infant during this delivery
(3) Wishing no birth review after delivery

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Aya
Middle name
Last name Tezuka

Organization

Institute of Science Tokyo

Division name

Graduate School of Health Sciences

Zip code

1138510

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

TEL

0358037225

Email

tezuka.a.4644@m.isct.ac.jp


Public contact

Name of contact person

1st name Aya
Middle name
Last name Tezuka

Organization

Institute of Science Tokyo

Division name

Graduate School of Health Sciences

Zip code

1138510

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

TEL

0358037225

Homepage URL


Email

tezuka.a.4644@m.isct.ac.jp


Sponsor or person

Institute

Institute of Science Tokyo

Institute

Department

Personal name



Funding Source

Organization

Japan Academy of Midwifery

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee for Medical Sciences, Institute of Science Tokyo

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

Tel

0358034547

Email

rinri.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京科学大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 09 Month 15 Day

Date of IRB

2026 Year 10 Month 27 Day

Anticipated trial start date

2026 Year 11 Month 16 Day

Last follow-up date

2027 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 08 Month 04 Day

Last modified on

2026 Year 11 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071471